Published in Biochemistry on May 06, 2008
Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. Thromb Haemost (2016) 0.75
Leptospira Infection Interferes with the Prothrombinase Complex Assembly during Experimental Leptospirosis. Front Microbiol (2017) 0.75
On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32
The coagulation cascade: initiation, maintenance, and regulation. Biochemistry (1991) 6.29
The molecular basis of blood coagulation. Cell (1988) 5.29
The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J (1989) 4.49
Blood coagulation. Annu Rev Biochem (1980) 4.27
Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood (1990) 3.38
The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem (1980) 2.39
Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem (1988) 2.20
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Conversion of thrombin into an anticoagulant by protein engineering. Nature (1995) 1.98
Exosite-driven substrate specificity and function in coagulation. J Thromb Haemost (2005) 1.81
Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem (1994) 1.77
The Na+ binding site of thrombin. J Biol Chem (1995) 1.77
Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry (1986) 1.62
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J (2006) 1.59
Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem (2000) 1.52
Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases. Proc Natl Acad Sci U S A (1996) 1.39
The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem (1987) 1.36
The molecular environment of the Na+ binding site of thrombin. Biophys Chem (1997) 1.29
Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry (2002) 1.22
Quantification of cation-pi interactions in protein-ligand complexes: crystal-structure analysis of Factor Xa bound to a quaternary ammonium ion ligand. Angew Chem Int Ed Engl (2005) 1.20
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery. J Biol Chem (2004) 1.17
Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site. J Biol Chem (2002) 1.13
Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J Biol Chem (1981) 1.12
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
Unexpected crucial role of residue 225 in serine proteases. Proc Natl Acad Sci U S A (1999) 1.11
Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex. J Biol Chem (2003) 1.09
Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation. J Biol Chem (2000) 1.08
The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. J Biol Chem (1992) 1.08
The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombinase complex. J Biol Chem (2004) 1.05
Sodium binding site of factor Xa: role of sodium in the prothrombinase complex. Biochemistry (2000) 1.00
Definition of a factor Va binding site in factor Xa. J Biol Chem (2000) 0.97
Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J Mol Biol (1998) 0.96
Role of the alpha-helix 163-170 in factor Xa catalytic activity. J Biol Chem (2007) 0.94
Structure of the prothrombin- and blood clotting factor X-membrane complexes. Biochemistry (1977) 0.94
Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding. J Biol Chem (2000) 0.94
The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. J Mol Biol (1997) 0.92
Identification and characterization of the sodium-binding site of activated protein C. J Biol Chem (1999) 0.90
Residue Asp-189 controls both substrate binding and the monovalent cation specificity of thrombin. J Biol Chem (2003) 0.89
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci U S A (2007) 1.87
The influence of sodium ion binding on factor IXa activity. Thromb Haemost (2006) 1.47
Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost (2008) 1.35
Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties. J Biol Chem (2007) 1.34
Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry (2002) 1.22
Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood (2011) 1.22
Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry (2002) 1.22
Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z. J Biol Chem (2008) 1.15
Ixolaris: a factor Xa heparin-binding exosite inhibitor. Biochem J (2005) 1.14
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex. J Biol Chem (2003) 1.09
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. J Biol Chem (2005) 1.07
Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1. J Biol Chem (2010) 1.07
Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin. J Biol Chem (2007) 1.06
Exosite-dependent regulation of factor VIIIa by activated protein C. Blood (2003) 1.04
Localization of the heparin binding exosite of factor IXa. J Biol Chem (2002) 1.04
Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1. J Biol Chem (2007) 1.04
Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb Haemost (2009) 1.02
Localization of phosphatidylserine binding sites to structural domains of factor Xa. J Biol Chem (2001) 1.02
Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase. J Cell Physiol (2009) 0.98
One- and two-metal ion catalysis: global single-turnover kinetic analysis of the PvuII endonuclease mechanism. Biochemistry (2008) 0.97
FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa. Biochem J (2007) 0.97
Contribution of basic residues of the autolysis loop to the substrate and inhibitor specificity of factor IXa. J Biol Chem (2003) 0.97
Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor. Biochemistry (2009) 0.96
Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci (2007) 0.95
Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci U S A (2006) 0.94
The conformation of the activation peptide of protein C is influenced by Ca2+ and Na+ binding. J Biol Chem (2004) 0.93
Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors. Thromb Haemost (2007) 0.93
Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa. J Biol Chem (2008) 0.93
Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases. Blood (2004) 0.92
Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor. J Biol Chem (2011) 0.92
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry (2007) 0.90
The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C. J Biol Chem (2003) 0.90
Role of the N-terminal epidermal growth factor-like domain of factor X/Xa. J Biol Chem (2004) 0.90
Antithrombin up-regulates AMP-activated protein kinase signalling during myocardial ischaemia/reperfusion injury. Thromb Haemost (2014) 0.88
Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol (2003) 0.87
Characterization of the heparin-binding site of the protein z-dependent protease inhibitor. Biochemistry (2012) 0.87
Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain. J Biol Chem (2004) 0.86
Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. J Biol Chem (2003) 0.86
Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin. J Cell Biochem (2012) 0.86
Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Rep (2013) 0.85
Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase. Thromb Haemost (2012) 0.85
The cofactor function of the N-terminal domain of tissue factor. J Biol Chem (2004) 0.85
Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry (2009) 0.85
Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution. Biochemistry (2012) 0.85
Expression, purification and characterization of factor IX derivatives using a novel vector system. Protein Expr Purif (2006) 0.84
Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin. Biochemistry (2004) 0.84
Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa. Thromb Haemost (2009) 0.83
Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells. J Cell Physiol (2014) 0.82
Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa. J Biol Chem (2010) 0.81
Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex. Biochemistry (2005) 0.81
Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells. Biochemistry (2012) 0.81
The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade. Thromb Haemost (2013) 0.81
Mutagenesis studies toward understanding allostery in thrombin. Biochemistry (2009) 0.81
Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1. J Cell Physiol (2010) 0.81
The functional significance of the autolysis loop in protein C and activated protein C. Thromb Haemost (2005) 0.79
Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms. Thromb Res (2009) 0.79
Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa. J Biol Chem (2013) 0.79
Activated protein C protects against renal ischaemia/reperfusion injury, independent of its anticoagulant properties. Thromb Haemost (2016) 0.78
Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C. Biochim Biophys Acta (2008) 0.77
Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells. Thromb Haemost (2007) 0.77
Equilibrium studies of the effect of difference in sequence homology on the mechanism of denaturation of bovine and horse cytochromes-c. Biochim Biophys Acta (2003) 0.77
Autolysis loop restricts the specificity of activated protein C: analysis by FRET and functional assays. Biophys Chem (2008) 0.77
Proexosite-1-dependent recognition and activation of prothrombin by taipan venom. J Biol Chem (2004) 0.76
Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. Exp Clin Transplant (2009) 0.76
Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa. Biochemistry (2013) 0.75
Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases. Biochem Biophys Res Commun (2009) 0.75
Inhibitory properties of the P1 Tyr variant of antithrombin. Biochemistry (2010) 0.75